HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas Brenn Selected Research

Acrospiroma

1/2020Clinicopathologic Characterization of Hidradenoma on Acral Sites: A Diagnostic Pitfall With Digital Papillary Adenocarcinoma.
1/2019ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma.
10/2006Mohs micrographic surgery, sentinel lymph node mapping, and estrogen receptor analysis for the treatment of malignant nodular hidradenoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas Brenn Research Topics

Disease

9Neoplasms (Cancer)
01/2022 - 09/2008
8Melanoma (Melanoma, Malignant)
01/2022 - 12/2011
3Acrospiroma
01/2020 - 10/2006
3Sarcoma (Soft Tissue Sarcoma)
01/2018 - 12/2011
2Neoplasm Metastasis (Metastasis)
01/2022 - 04/2012
2Carcinoma (Carcinomatosis)
06/2021 - 01/2017
2Adenoid Cystic Carcinoma (Cylindroma)
01/2017 - 10/2013
1Sweat Gland Neoplasms
01/2020
1Nevus (Nevi)
01/2019
1Vasculitis (Vasculitides)
11/2017
1Papillary Adenocarcinoma
01/2017
1Mucinous Adenocarcinoma (Mucinous Carcinoma)
01/2017
1Alopecia (Baldness)
01/2016
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
08/2009
1Lymphopenia (Lymphocytopenia)
09/2008
1Hemangiosarcoma (Angiosarcoma)
08/2005
1Fibrosis (Cirrhosis)
02/2004
1Marfan Syndrome (Marfan's Syndrome)
08/2002

Drug/Important Bio-Agent (IBA)

4Biological ProductsIBA
06/2021 - 10/2013
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2013
3DNA (Deoxyribonucleic Acid)IBA
01/2019 - 01/2013
2MART-1 AntigenIBA
11/2021 - 12/2011
21018 oligonucleotideIBA
08/2009 - 09/2008
1Keratins (Keratin)IBA
01/2022
1Interleukin-2 (IL2)IBA
01/2022
1Indicators and Reagents (Reagents)IBA
01/2022
1S100 Proteins (S 100 Protein)IBA
11/2021
1MicroRNAs (MicroRNA)IBA
07/2020
1Eosine Yellowish-(YS) (Eosin)IBA
01/2020
1Hematoxylin (Haematoxylon)IBA
01/2020
1Phosphotransferases (Kinase)IBA
01/2019
1GlucocorticoidsIBA
11/2017
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2017
1MucinsIBA
01/2017
1CeramidesIBA
01/2016
1Telomerase (Telomerase Reverse Transcriptase)IBA
04/2014
1Proteins (Proteins, Gene)FDA Link
01/2013
1Galectin 3 (LGALS3)IBA
04/2012
1Rituximab (Mabthera)FDA Link
08/2009
1Protein Subunit VaccinesIBA
09/2008
1CPG-oligonucleotideIBA
09/2008
1Vaccine AdjuvantsIBA
09/2008
1AntigensIBA
09/2008
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
09/2008
1Estrogen ReceptorsIBA
10/2006
1HemosiderinIBA
02/2004
1microfibrillar proteinIBA
08/2002
1Fibrillin-1IBA
08/2002

Therapy/Procedure

1Therapeutics
01/2022
1Immunotherapy
01/2022
1Biological Therapy
08/2009
1Injections
09/2008
1Mohs Surgery (Mohs' Micrographic Surgery)
10/2006
1Radiotherapy
08/2005